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Deﬁning the phospho-adhesome through the
phosphoproteomic analysis of integrin signalling
Joseph Robertson1, Guillaume Jacquemet1,w, Adam Byron1,w, Matthew C. Jones1, Stacey Warwood2,
Julian N. Selley2, David Knight2, Jonathan D. Humphries1 & Martin J. Humphries1
Cell–extracellular matrix (ECM) adhesion is a fundamental requirement for multicellular
existence due to roles in positioning, proliferation and differentiation. Phosphorylation plays a
major role in adhesion signalling; however, a full understanding of the phosphorylation events
that occur at sites of adhesion is lacking. Here we report a proteomic and phosphoproteomic
analysis of adhesion complexes isolated from cells spread on ﬁbronectin. We identify 1,174
proteins, 499 of which are phosphorylated (1,109 phosphorylation sites), including both
well-characterized and novel adhesion-regulated phosphorylation events. Immunoblotting
suggests that two classes of phosphorylated residues are found at adhesion sites—those
induced by adhesion and those constitutively phosphorylated but recruited in response to
adhesion. Kinase prediction analysis identiﬁes novel kinases with putative roles in adhesion
signalling including CDK1, inhibition of which reduces adhesion complex formation. This
phospho-adhesome data set constitutes a valuable resource to improve our understanding of
the signalling mechanisms through which cell–ECM interactions control cell behaviour.
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C
ellular adhesion to the extracellular matrix (ECM),
mediated by adhesion receptors such as integrins and
syndecans, initiates or modulates signalling pathways that
control a range of cell functions including proliferation, survival,
differentiation and migration1–3. Accordingly, adhesion plays an
important role in processes such as development, wound healing
and inﬂammation, while aberrant adhesion is associated with
diseases such as immunodeﬁciency, bleeding disorders and
cancer4,5. Adhesion signalling is orchestrated through large and
diverse multiprotein complexes that are recruited to sites of cell–
ECM engagement (adhesion complexes). Literature-based
analyses of adhesion complexes have revealed highly connected
networks of at least 180 distinct components (collectively termed
the integrin ‘adhesome’)5–7, including cytoskeletal linkers and
regulators, and enzymes involved in a plethora of cell signalling
pathways. More recently, the development of methodologies for
the isolation of adhesion complexes has enabled mass
spectrometry (MS)-based proteomic proﬁling of their molecular
composition8–12. Such proteomic approaches have begun to
reveal the true diversity and complexity of the adhesome, as well
as provide insights into how adhesion complex composition
varies in an integrin heterodimer- and tension-dependent
manner8–13.
Reversible phosphorylation of serine, threonine and tyrosine
residues is a prominent signalling mechanism to enable spatial
and temporal regulation of the activation states, conformations or
binding interactions of proteins and thereby regulate diverse
downstream effects14. Phosphorylation is postulated to play an
important and widespread role in signalling within adhesion
sites6. For example, a large number of kinases and phosphatases
are recruited to adhesion sites, and several of these enzymes are
highly connected within the adhesome network (forming putative
‘hubs’)7. Furthermore, a number of tyrosine phosphorylation
events on adhesome proteins such as FAK, Src, paxillin and
p130Cas are induced by adhesion and play important functional
roles in integrin signalling15–18. Indeed, the immunostaining of
ECM-adherent cells using generic anti-phosphotyrosine
antibodies has revealed that, in general, adhesion sites possess
high levels of tyrosine-phosphorylated proteins18–21. Although
systems-level analyses of adhesion-induced phosphorylation
events have been performed11,22, a detailed catalogue of the
phosphorylation sites found speciﬁcally on proteins within
adhesion complexes is lacking. Here we have addressed this
deﬁcit by applying a combination of proteomic and
phosphoproteomic methodologies to the analysis of isolated
adhesion complexes, and thereby have generated data sets that
can be utilized to provide novel insights into the mechanisms of
adhesion signalling. For example, by validating a number of the
identiﬁed phosphorylation sites by immunoblotting, we have
identiﬁed distinct populations of adhesion-induced and adhesion-
independent phosphorylation sites that are recruited to adhesion
complexes. Moreover, these data sets may have wide-ranging
implications for other areas of biological research, highlighting
potential novel links with cellular adhesion. To this end, we have
identiﬁed a number of protein kinases with putative novel roles in
adhesion signalling, and shown that one such kinase, cyclin-
dependent kinase 1 (CDK1), has a role in regulating adhesion
complex formation.
Results
Proteomic and phosphoproteomic analysis of adhesion complexes.
To deﬁne the protein and phosphoprotein composition of adhesion
sites, a combined proteomic and phosphoproteomic workﬂow
was used to analyse adhesion complexes isolated from cells spread on
the ECM protein ﬁbronectin (FN; Fig. 1a). To aid the identiﬁcation
of speciﬁc, integrin-associated proteins, complexes were also isolated
from cells spread on the control substrate transferrin (Tf) and
analysed using the same workﬂow. Immunoblotting of isolated
complexes demonstrated that a5 integrin (a subunit of the
FN-binding integrin a5b1) and the well-characterized adhesion
complex proteins paxillin and talin were enriched in FN-induced
adhesion complexes, while the Tf receptor (TfR) was enriched in
Tf-induced protein complexes (Fig. 1b). Non-adhesion-associated
proteins (from various cellular compartments) such as mitochondrial
heat shock protein (HSP)-70, HSP90 (cytoplasm), Naþ /Kþ -ATPase
(plasma membrane), TfR (plasma membrane and endosome),
BAK (mitochondria), calnexin (endoplasmic reticulum) and
lamin B1 (nucleus) were not detected to a signiﬁcant level in the
complexes isolated from cells spread on either ligand (Fig. 1b).
Furthermore, the well-characterized adhesion-induced phospho-
rylation sites on FAK and Src (pY397 and pY416, respectively)
were speciﬁcally detected in FN-induced adhesion complexes
(Fig. 1b). Together these data demonstrate that the isolation method
speciﬁcally enriched and retained adhesion complex proteins,
including those containing phosphorylation sites that were pre-
viously reported to be phosphorylated in response to integrin-
mediated adhesion to the ECM.
Proteomic and phosphoproteomic analyses identiﬁed 859
proteins and 499 phosphoproteins (containing a total of 1,109
phosphorylation sites) that were speciﬁcally detected in FN-
induced adhesion complexes (following subtractive comparisons
with controls; Supplementary Data 1–4). Compared with
previous proteomic analyses of adhesion complexes isolated from
cells spread on FN, the proteomic data set collected here
contained a similar number of proteins and displayed a similar
level of detection of previously deﬁned adhesome components
(65; 36% of the adhesome)13. Many well-characterized adhesion
complex proteins such as talin, vinculin, FAK and paxillin were
detected in the proteomic data set, as well as the two FN-binding
integrin heterodimers a5b1 and avb3. The phosphoproteomic
data set, however, contained a large number of proteins (315) that
were not identiﬁed by the proteomic analysis. Thus, the total
number of identiﬁed adhesion complex proteins was substantially
increased by merging the proteomic and phosphoproteomic data
sets (from 859 to 1,174; an increase of 36%; Fig. 1c). Notably, 19
of the proteins identiﬁed only in the phosphoproteomic
analysis were previously deﬁned adhesome components,
providing conﬁdence that the extra proteins identiﬁed by
phosphoproteomic analysis were genuine adhesion complex
proteins. Interestingly, 10 of these adhesome proteins have not
been identiﬁed in any other published adhesion complex
proteomic analyses8–12 (Fig. 1c). These ﬁndings indicate that
performing a combined proteomic and phosphoproteomic
analysis of isolated adhesion complexes can generate a more
comprehensive and representative catalogue of components than
is possible by proteomic analysis alone.
Comparing adhesion complex and whole cell phosphopro-
teomes. To assess the speciﬁcity of adhesion-associated phos-
phoprotein detection from phosphoproteomic analysis of isolated
adhesion complexes, gene ontology (GO) enrichment analysis of
the 499 phosphoproteins identiﬁed from isolated adhesion com-
plexes was performed. This revealed a signiﬁcant enrichment of
biological process (BP) terms associated with adhesion biology
(such as ‘regulation of cytoskeleton organization’ and ‘regulation
of small GTPase-mediated signal transduction’; Supplementary
Fig. 1a and Supplementary Data 5). As whole-cell lysates (WCLs)
are conventionally used for phosphoproteomic analyses, we also
performed a phosphoproteomic analysis of the WCLs of cells
spread on FN and searched the resulting data set for the
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Figure 1 | Combined proteomic and phosphoproteomic analysis of isolated adhesion complexes. (a) Schematic workﬂow for the isolation and
proteomic/phosphoproteomic analysis of adhesion complexes. Cells were allowed to spread on FN or, as a control, Tf and complexes were isolated by a
combination of crosslinking, cell lysis and a high-pressure wash to remove cell bodies. Collected complexes were analysed using either a proteomic or
phosphoproteomic workﬂow, after which the FN-speciﬁc proteins and phosphoproteins were identiﬁed by performing a subtractive comparison with
controls. (b) Immunoblot analysis of complexes isolated from cells spread on FN and Tf, as well as the WCLs of cells spread on FN. M, MWmarkers (kDa;
values displayed to the left of each blot). Dashed lines indicate where images have been cropped for display purposes. (c) A Venn diagram showing the
overlap between the FN-speciﬁc proteins (left circle) and phosphoproteins (right circle) identiﬁed by proteomic and phosphoproteomic analyses of isolated
complexes, respectively. In addition to the total number of proteins (black text), the number of adhesome proteins identiﬁed in each data set is also
displayed (red text). To the right of the panel, all 19 adhesome components identiﬁed exclusively by the phosphoproteomic analysis are displayed. Proteins
in bold text were not identiﬁed by any other proteomic analyses of isolated FN-induced adhesion complexes.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7265 ARTICLE
NATURE COMMUNICATIONS | 6:6265 | DOI: 10.1038/ncomms7265 | www.nature.com/naturecommunications 3
& 2015 Macmillan Publishers Limited. All rights reserved.
enrichment of BP terms. Compared with isolated adhesion
complexes, analysis of the WCL data set (735 phosphoproteins)
revealed a very different set of enriched BP terms (Supplementary
Fig. 1b), with many of the highest ranking BP terms related to
RNA processing or the cell nucleus (for example, ‘chromosome
organization’ and ‘DNA metabolic process’; Supplementary
Fig. 1c and Supplementary Data 6). GO enrichment analyses of
other WCL data sets collected in phosphoproteomic studies
(involving different cell types, experimental conditions and total
numbers of phosphoproteins23,24) revealed an enrichment of
similar BP terms to those enriched in the WCL data set collected
in the present study (for example, the highest ranking term was
‘RNA processing’ for all data sets; Supplementary Fig. 1c;
Supplementary Data 6–8). Collectively, these data indicate that
a substantial proportion of the most abundant phosphorylation
sites in cells belong to proteins involved in RNA-related cellular
processes. Notably, terms enriched in WCL data sets relating to
RNA processing or the cell nucleus (Supplementary Fig. 1c) were
not enriched in the isolated adhesion complex data set collected
in this study (Supplementary Data 5). This indicates that
phosphoproteins identiﬁed from isolated adhesion complexes
are speciﬁc to the adhesion machinery of the cell, and that the
bulk of the cellular phosphoproteome had been removed on
adhesion complex isolation.
The speciﬁcity afforded by analysing isolated adhesion
complexes enabled the detection of a number of phosphorylation
sites that are known to be upregulated by adhesion to the ECM.
These included sites on FAK (pY397, pY576 and pY577), paxillin
(pY118) and six phosphotyrosine residues within the substrate
domain of p130Cas, all of which have been shown to be
stimulated by cell spreading on ECM ligands25–27. In addition,
the phosphorylation sites were detected from other well-deﬁned
adhesion complex proteins that are less well documented to be
phosphorylated in an adhesion-dependent manner. These
included b1 integrin (pT777 and pY783), b3 integrin (pY773
and pY785), talin-1 (pY127, pT144, pS425, pY436 and pS2040),
vinculin (pS290), kindlin-2 (pS159, pY179 and pS181),
p190RhoGAP (pS589 and pY1105) and GIT1 (pY383, pS385,
pS592, pS596 and pT601). It is notable that the majority of these
sites were only detected through analysis of isolated adhesion
complexes (none of the well-characterized adhesion-regulated
phosphorylation sites on FAK, paxillin or p130Cas were detected
through phosphoproteomic analysis of the WCLs of cells
spread on FN performed in this study). These phosphorylation
sites were also not detected in two large-scale adhesion-based
phosphoproteomic studies in which the WCLs of cells spread on
FN or collagen were analysed11,22. These observations indicate
that many phosphorylation sites on adhesion complex proteins
are of low abundance in the context of the whole-cell
phosphoproteome, and are therefore difﬁcult to detect within
complex WCLs. As a result, the phosphoproteomic analysis of
isolated adhesion complexes performed here enabled a more
detailed coverage of phosphorylation events from adhesion
structures.
Creation of a phospho-adhesome network. To view the current
literature-based depiction of the adhesome network7 in the
context of the regulatory role of phosphorylation, a protein–
protein interaction (PPI) network was constructed for all detected
adhesome proteins. The network was arranged according to the
functional subnetworks of the adhesome and overlaid with
information on the number of phosphorylation sites detected in
each protein (Fig. 2a). This revealed that phosphorylation is
highly abundant among the identiﬁed adhesome components—of
the 84 adhesome proteins that were detected, 50 were
phosphorylated (on a total of 164 phosphorylation sites; the
total number of phosphorylation sites per protein ranged from
one to sixteen). In total, nine of the detected adhesome subnets
contained at least one phosphoprotein, consistent with a
widespread role for phosphorylation in the regulation of
adhesion complex proteins. Furthermore, it is noteworthy that
FAK and paxillin, two of the most highly connected proteins in
the PPI network (thus representing putative essential ‘hubs’),
were also two of the most highly phosphorylated adhesome
proteins, highlighting the potentially fundamental role for
phosphorylation in the regulation of protein interactions within
adhesion sites. The scaffolding network of the adhesome
(receptors, adaptors, actin regulators and actin) appeared,
in general, to be highly regulated by phosphorylation,
although distinct patterns were observed for individual subnets.
For example, all ﬁve of the identiﬁed receptors were
phosphorylated, although these proteins possessed low numbers
of phosphorylated residues (r2). Unlike the receptors, the
identiﬁed adaptors and actin regulators displayed a large
variation in the numbers of detected phosphorylation sites.
Approximately half were not phosphorylated; however, eight of
the nine most highly phosphorylated adhesome proteins were
adaptors and actin regulators (six adaptors and two actin
regulators, all of which were detected with six or more
phosphorylation sites).
Outside of the scaffolding proteins, a large proportion of the
identiﬁed guanine nucleotide exchange factors (GEFs) and
GTPase-activating proteins (GAPs) from the adhesome were
phosphorylated (Fig. 2a). The GAPs and GEFs appeared to be
predominantly regulated by serine/threonine rather than tyrosine
phosphorylation, with the GEFs subnet being the only subnet
from which no tyrosine phosphorylation sites were detected.
Interestingly, this pattern of phosphorylation was observed not
only for the detected adhesome proteins, but for the whole data
set: the majority of phosphorylation sites detected from all
identiﬁed GEFs and GAPs were serines and threonines, with very
few phosphorylated tyrosine residues (Fig. 2b). This was
especially the case for the GEFs, from which only one tyrosine
residue was detected on intersectin-2, which also functions as an
adaptor. These data conﬁrm and extend one of the observations
of the literature-based analysis of adhesome components, which
highlighted that GEFs are primarily regulated by serine/threonine
kinases7. Conversely, the literature-based adhesome analysis also
indicated that GAPs are primarily regulated by tyrosine kinases7,
which is not consistent with the relatively high levels of serine and
threonine phosphorylation detected on GAPs in this study. Thus,
the data collected here both corroborate the previous observation
from the literature that serine/threonine kinases play a prominent
role in the regulation of GEFs, as well as provide novel insights
into adhesion signalling that were not possible through extensive
mining of the literature.
Analysis of b1 integrin-proximal phosphorylation events. To
provide a wider view of the proteins and phosphoproteins iden-
tiﬁed from adhesion complexes, a PPI network was constructed
for proteins within one- and two-binding interactions of integrin
b1 (Supplementary Fig. 2). This network was substantially larger
and more complex than the adhesome component network: 369
proteins and phosphoproteins (31% of the total protein and
phosphoprotein data set) were within the 2-hop neighbourhood
of b1 integrin (39 and 330 within one and two binding interac-
tions, respectively). Of the 369 proteins in the 2-hop neigh-
bourhood, 168 were phosphorylated (46%). These included a
number of proteins that do not have well-characterized roles in
integrin-mediated signalling.
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Figure 2 | The FN-induced phospho-adhesome. (a) Adhesome components6 identiﬁed from the combined proteomic and phosphoproteomic analysis of
isolated adhesion complexes were mapped onto a human PPI network and organized according to functional category. Grey nodes represent proteins
identiﬁed by the proteomic analysis but not the phosphoproteomic analysis (no phosphorylation). All other nodes represent proteins identiﬁed by the
phosphoproteomic analysis and are displayed as pie charts showing the relative levels of phosphorylated serine, threonine and tyrosine residues on each
protein. These nodes are also displayed in different sizes to reﬂect the total number of phosphorylated residues identiﬁed from each protein. (b) All
phosphorylated GEFs and GAPs identiﬁed from isolated adhesion complexes are displayed. Nodes surrounded by a grey box represent adhesome
components.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7265 ARTICLE
NATURE COMMUNICATIONS | 6:6265 | DOI: 10.1038/ncomms7265 | www.nature.com/naturecommunications 5
& 2015 Macmillan Publishers Limited. All rights reserved.
The percentages of tyrosine phosphorylation for both the
adhesome components (Fig. 2a) and the proteins in the b1
integrin one-hop neighbourhood (Supplementary Fig. 2) were
23% (Fig. 3a,b): a much higher percentage than that observed for
the whole data set (7%; Fig. 3e). In fact, the percentage of
tyrosine-phosphorylated residues on adhesion complex proteins
correlated with proximity to b1 integrin (Fig. 3a–d). However, it
is noteworthy that the proportion of tyrosine phosphorylation
observed for the whole data set (7%; Fig. 3e) is also higher than
that typically observed in larger-scale cell or tissue lysate-based
phosphoproteomic studies (B2%) (refs 28,29). These
observations suggest that, compared with the whole-cell
phosphoproteome, adhesion complexes are generally enriched
for phosphotyrosine, and that this phosphotyrosine enrichment is
more prominent for b1 integrin-proximal proteins.
Validation of adhesion complex-speciﬁc phosphorylation sites.
To interrogate and validate the phosphoproteomic data further,
immunoblotting and immunoﬂuorescence analyses were per-
formed using antibodies targeting both well-characterized adhe-
sion-regulated phosphorylation sites and phosphorylation sites
that are not known to be upregulated by adhesion to FN (Fig. 4).
Consistent with MS data, immunoblotting analyses demonstrated
that phosphorylation sites on paxillin (pY118), FAK (pY397,
pTyr407 and pY576), MYPT1 (pT696), cortactin (pY421) and
SHP2 (pY580) were all enriched to isolated adhesion complexes
compared with controls (Fig. 4a). Probing for PKCd pY313
produced a faint band that was speciﬁc to adhesion complexes
and matched with the molecular weight (MW) of PKCd (82 kDa;
white arrow); however, an intense, higher-MW adhesion com-
plex-speciﬁc double band (between 100 and 150 kDa; black
arrow) was also observed. These data are consistent with a pre-
vious study reporting a 130-kDa isoform of PKCd30, and suggest
that both isoforms of the protein are recruited to adhesion
complexes, with the higher-MW isoform being present in
particularly high abundance.
Immunoﬂuorescence analyses were consistent with both MS
data and immunoblotting, demonstrating that the phosphoryla-
tion sites FAK pY407, cortactin pY421 and PKCd pY313 co-
localized with paxillin (a marker for adhesion complexes) in cells
adherent to FN (Fig. 4b). Collectively, these data validated several
components of the phosphoproteomic data set collected in this
study and indicated that the data set as a whole represents
genuine phosphorylation events in the adhesion complex
signalling machinery. It was therefore anticipated that these
phosphorylation sites would be regulated by adhesion and that
this regulation would be detectable by immunoblotting of the
lysates of ECM-engaged cells. To test this hypothesis, WCLs of
cells spread on FN or Tf were immunoblotted using the same
antibodies as used for MS data validation (Fig. 4c). As expected,
the well-documented adhesion-regulated phosphorylation site
paxillin pY118 was detected at much higher levels from the
lysates of cells spread on FN compared with controls. Similar
levels of adhesion-dependent upregulation were observed for two
other phosphorylation sites from well-characterized components
of integrin signalling pathways: FAK pY397 and pY576.
Conversely, FAK pY407 was detected at similar levels from
WCLs of cells spread on FN and Tf. Thus, although FAK pY407
was clearly present within adhesion complexes (Fig. 4a,b), the
abundance of this phosphorylation site in cells did not appear to
be substantially upregulated by cellular adhesion to FN (Fig. 4c).
Intriguingly, other phosphorylation sites that were detected
speciﬁcally from adhesion complexes showed similar patterns of
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detection to FAK pY407 (for example, MYPT1 pT696 and
cortactin pY421; Fig. 4c).
Unlike immunoblot analysis of isolated adhesion complexes, a
SHP2 pY580 band could not be detected from cell lysates
(Fig. 4a,c). This suggests that the level of SHP2 pY580 in whole
cells is too low to be detected by immunoblotting, but speciﬁc
isolation (and therefore enrichment) of adhesion complex
proteins can facilitate detection by both immunoblotting and
MS. Immunoblotting for PKCd pY313 again produced two bands
of distinct MW, presumably representing two different isoforms.
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The band that matched with the expected MW of PKCd (82 kDa)
was detected at low and equal levels in the lysates of cells spread
on FN and Tf (Fig. 4c; white arrow); however, the putative
higher-MW isoform was present at much higher levels in the
lysates of adherent cells compared with controls (Fig. 4c; black
arrow). This indicates that, like pY118 of paxillin and pY397 and
pY576 of FAK, pY313 of the higher-MW PKCd isoform was
upregulated by cell spreading on FN.
Collectively, these data validate the phosphoproteomic data
retrieved from isolated adhesion complexes in this study, and also
reveal that two populations of phosphorylation sites are present
within adhesion sites: one that is substantially upregulated in
response to adhesion, and one that appears to be constitutively
phosphorylated in an adhesion-independent manner.
Predicted kinase activities in adhesion-mediated signalling. To
identify protein kinases that are potentially involved in adhesion
signalling, the GPS kinase prediction tool31 was used to
interrogate adhesion complex phosphorylation sites (Fig. 5 and
Supplementary Fig. 3). Of the 1,109 phosphorylation sites
detected, 865 (78%) were identiﬁed as potential substrates for a
particular protein kinase or group/family of protein kinases
(Supplementary Data 9).
In addition to adhesion-associated kinases such as FAK and Src
(Supplementary Fig. 3), the kinase prediction tool identiﬁed a
large number of kinases that do not have well-characterized roles
in integrin signalling (Fig. 5). For example, serine/threonine
kinases of the CMGC group (including the CDK, glycogen
synthase kinase and mitogen-activated protein kinase families)
and the AGC group (including the protein kinase A and C
families) were predicted to phosphorylate particularly large
numbers of the phosphorylation sites identiﬁed from adhesion
complex proteins (Fig. 5).
CDKs play a fundamental role in regulating the cell cycle32, but
are not generally considered to be involved in the regulation of cell
adhesion or to phosphorylate substrates within adhesion
complexes. However, the kinase prediction tool identiﬁed a large
number of phosphorylation sites from adhesion complex proteins
as potential CDK targets (CDK1, 185 sites; CDK2, 199 sites; CDK4,
156 sites; CDK5, 145 sites; CDK6, 126 sites; CDK7, 59 sites;
Supplementary Data 9), suggesting that these kinases may play a
role in adhesion signalling. Therefore, to validate the kinase
prediction tool results, the impact of CDK1 inhibition on cell
adhesion and spreading was tested. Treatment of A375 cells and
human foreskin ﬁbroblasts (HFFs) with the CDK1-speciﬁc
inhibitor RO-3306 (refs 33,34) triggered the disassembly of
focal adhesions and a decrease in the area of cells covered by
adhesions, leaving only small adhesions at the cell periphery that
resembled nascent adhesions (Fig. 6a,b). Furthermore, treatment
of cells with two alternative inhibitors of CDK1 activity also
resulted in a signiﬁcant decrease in the area of cells covered by
adhesions (Supplementary Fig. 4). These ﬁndings highlight a role
for CDK1 in the regulation of adhesion sites in non-dividing cells,
and illustrate how the global analysis of adhesion site-speciﬁc
phosphorylation events can be utilized to gain novel insights into
the signalling networks that function downstream of adhesion
receptor ligation.
Discussion
The ligation of integrin receptors by their ECM ligands initiates
highly complex intracellular signalling pathways that inﬂuence
various fundamental aspects of cell behaviour. However, a
comprehensive understanding of the molecular mechanisms that
translate cell–ECM interactions into functional responses is
lacking. To address this issue, we have generated the ﬁrst global
view of the protein and phosphoprotein composition of adhesion
complexes. Although it has been previously postulated that
phosphorylation plays a widespread role in regulating adhesion
complex proteins6,7, this study provides the ﬁrst experimental
evidence of the high abundance of phosphorylation within
adhesion complexes, and conﬁrms the pivotal role played by
this post-translational modiﬁcation in adhesion signalling.
Many of the identiﬁed phosphorylation sites belonged to well-
characterized adhesion complex proteins and represented estab-
lished adhesion-induced signalling events. Notably, this coverage
of adhesion-associated phosphoproteins was superior to that
observed when more complex cell lysates were utilized (both here
and in previous adhesion-based studies11,22). These ﬁndings
support the notion that analysing subcellular compartments
increases the sensitivity of detection for lower abundance
phosphorylation sites35. However, notwithstanding the clear
beneﬁts achieved through speciﬁc analysis of adhesion complex
proteins, it should be highlighted that this approach comes at the
expense of detecting more distal signalling events within the cell
that are induced by adhesion. Thus, in-depth analysis of the
whole-cell phosphoproteome remains an important goal for a
comprehensive analysis of adhesion receptor signalling.
The adhesion site-speciﬁc analysis performed here revealed a
general enrichment of phosphotyrosine within adhesion com-
plexes compared with whole-cell phosphoproteomes, an observa-
tion that is consistent with previous immunoﬂuorescence
analyses18–21. Indeed, it has been speculated that, in contrast to
serine/threonine phosphorylation that existed before the
evolution of integrin receptors in metazoa, tyrosine
phosphorylation-based signalling mechanisms developed
concomitantly with the emergence of integrins36. Thus, the
onset of cell signalling through tyrosine kinases and phosphatases
may have been a key enabling event in the evolution of
multicellular organisms36,37. While the data collected here
support this hypothesis, the high number of serine/threonine
phosphorylation sites identiﬁed from adhesion complex proteins
should not be overlooked. More than 90% of the phosphorylated
residues identiﬁed from adhesion complex proteins in the present
study were serines and threonines (82 and 11%, respectively).
This suggests that serine/threonine phosphorylation events,
relatively underappreciated in the context of cell adhesion until
now, play a key role in adhesion signalling.
Validation of the phosphoproteomic data collected here
revealed that all tested phosphorylation sites were present within
adhesion complexes. However, while some phosphorylation sites
were shown by immunoblotting to be dramatically upregulated
by adhesion (for example, FAK pY397 and pY576 and paxillin
pY118) others were shown by immunoblotting to be present at
similar levels in the lysates of adherent and non-adherent cells
(for example, FAK pY407, MYPT1 pT696 and cortactin pY421),
raising questions as to the extent of adhesion-dependent
upregulation of these residues. One explanation is that a small
proportion of the total cellular pool of these proteins is
phosphorylated on certain residues at adhesion sites, and a high
background of the same phosphorylation site elsewhere in the cell
prohibited the detection of its upregulation by immunoblotting
using WCLs. Alternatively, it is possible that these phosphoryla-
tion sites are not upregulated in response to cell spreading on FN.
Instead, some proteins may be recruited to adhesion sites in a
prephosphorylated state, potentially maintaining preassembled
protein complexes that have recently been shown to be recruited
to adhesion sites from the cytosol38. Conversely, these residues
could represent ‘passenger’ phosphorylation sites that are
phosphorylated before their recruitment to adhesion sites, but
do not perform a function within adhesion complexes.
Elucidating which of these scenarios best explains the ﬁndings
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of this study requires further work. In any case, it is clear that two
different types of phosphorylation site are found at adhesion
complexes: one that is present at very low levels in non-adherent
cells and undergoes substantial upregulation on cell spreading on
FN, and a second that is present at high basal levels in non-
adherent cells. It is notable that this insight was only made
possible as a result of the spatial context afforded by analysing
isolated adhesion complexes. The distinction between
phosphorylated residues that are present within adhesion
complexes versus those that are substantially upregulated in an
adhesion-dependent manner would not have been achievable
using cell lysates.
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Using the phosphoproteomic data generated from isolated
adhesion complexes, we have highlighted a large number of
kinases that are potentially involved in regulating adhesion
complex proteins. To conﬁrm the validity of these ﬁndings, we
have shown that CDK1 plays a role in regulating the formation of
adhesion complexes. Although CDK activity is typically asso-
ciated with regulating the cell cycle in the nucleus, previous
studies have revealed a role for different members of the CDK
family in regulating adhesion complex proteins including
talin39,40, paxillin41, actopaxin42 and ﬁlamin-A43. Furthermore,
increased expression of the integrin heterodimer avb3 has been
shown to upregulate CDK activity and thereby promote cell
migration44, and inhibition of CDK has previously been shown to
block the adhesion and migration of leukocytes45. Therefore, the
data collected here and elsewhere support the notion that CDK
activity is not restricted to regulation of the cell cycle, but is also
stimulated by ECM engagement and is involved in regulating cell
adhesion and migration. It will be interesting to determine
whether the many other putative novel adhesion-associated
kinases identiﬁed in this study play a similarly important role
in adhesion signalling.
In summary, the data presented here represent a catalogue of
the phosphorylation events found speciﬁcally within adhesion
complexes, and as such constitute a valuable resource to improve
our understanding of the molecular mechanisms through which
adhesion controls many aspects of cell behaviour.
Methods
Cell culture. A375-SM human melanoma cells (provided by I.J. Fidler, MD
Anderson Cancer Center, Houston, TX, USA) and HFFs were maintained in
Dulbecco’s modiﬁed Eagle’s medium (Sigma-Aldrich, Poole, UK) supplemented
with 10% (v/v) fetal calf serum (Lonza Bioscience, Slough, UK) and 2mM
L-glutamine at 37 C, 5% (v/v) CO2.
Reagents. Monoclonal antibodies used were mouse anti-b1 integrin (JB1A;
1:1,000; provided by J.A. Wilkins, University of Manitoba, Winnipeg, MB,
Canada), mouse anti-FAK (clone 77; 1:1,000; BD Biosciences, Oxford, UK;
610088), rabbit anti-FAK pY397 (clone 141-9; 1:1,000; Invitrogen, Paisley, UK;
44–625G), mouse anti-paxillin (clone 349; 1:10,000 for immunoblotting, 1:200 for
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Figure 6 | Effect of CDK1 inhibition on cell adhesion. A375 cells (a) and HFFs (b) were spread on FN for 60min before treatment with the CDK1-speciﬁc
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immunoﬂuorescence; BD Biosciences; 610051), mouse anti-HSP90 (EMD-17D7;
1:1,000; Millipore, Billerica, MA, USA; CA1023-50UG), rabbit anti-lamin B1
(D4Q4Z, 1:1,000; Cell Signaling Technology, Danvers, MA, USA; 12586S), mouse
anti-mitochondrial HSP70 (JG1; 1:1,000; Thermo Fisher Scientiﬁc, Waltham, MA,
USA; MA3028), rabbit anti-SHP2 pY580 (D66F10; 1:1,000; Cell Signaling Tech-
nology; 5431S), mouse anti-talin (8D4; 1:1,000; Sigma-Aldrich; T3287) and mouse
anti-TfR (H68.4; 1:1,000; Invitrogen; 13–6890). Polyclonal antibodies used were
rabbit anti-a5 integrin (H-104, 1:1,000; Santa Cruz Biotechnology, Santa Cruz, CA,
USA; sc-10729), rabbit anti-calnexin (1:1,000; Enzo Life Sciences, Exeter, UK;
ADI-SPA-860), rabbit anti-cortactin pY421 (1:1,000 for immunoblotting, 1:100 for
immunoﬂuorescence; Cell Signaling Technology; 4569S), rabbit anti-FAK pY407
(1:1,000 for immunoblotting, 1:100 for immunoﬂuorescence; Invitrogen;
44–650G), rabbit anti-FAK pY576 (1:1,000; Invitrogen; 44–652G), rabbit anti-
MYPT1 pT696 (1:1,000; Millipore; ABS45), rabbit anti-PKCd pY313 (1:1,000 for
immunoblotting, 1:100 for immunoﬂuorescence; Cell Signaling Technology;
2055S), rabbit anti-paxillin pY118 (1:1,000; Invitrogen; 44–722G) and rabbit anti-
Src pY416 (1:1,000; Cell Signaling Technology; 2101S). Secondary Alexa-Fluor 680-
conjugated (1:5,000; Invitrogen) or DyLight 800-conjugated (1:5,000; Cell Signaling
Technology) antibodies were used for immunoblotting. Secondary Alexa-Fluor
647-conjugated anti-mouse (1:200) and Alexa-Fluor 488-conjugated anti-rabbit
(1:200) antibodies were used for immunoﬂuorescence (both from Invitrogen).
Generation of isolated adhesion complexes and cell lysates. Subconﬂuent
A375-SM cells in culture were detached with trypsin (Sigma-Aldrich) and resus-
pended in Dulbecco’s modiﬁed Eagle’s medium supplemented with 25mM HEPES
(Sigma-Aldrich). Cells were then incubated in suspension for 20min at 37 C to
downregulate ECM adhesion signalling events. Cells were then allowed to spread
on 55-cm2 dishes (Corning, NY, USA) coated with 10 mgml 1 FN (Sigma-
Aldrich) or 10mgml 1 Tf (Sigma-Aldrich) for 120min at 37 C, 8% (v/v) CO2.
To isolate adhesion complexes, cells spread on FN or Tf were incubated with
the membrane permeable crosslinker dimethyl-3, 30-dithiobispropionimidate
(DTBP, Sigma-Aldrich; 3mM, 30min). Cells were then washed twice with PBS
(Sigma-Aldrich) and DTBP was quenched using 1M Tris (pH 8, 10min), after
which the cells were again washed twice using PBS and incubated in PBS at 4 C.
Cell bodies were then removed by a combination of cell lysis in RIPA buffer
(50mM Tris-HCl, pH 8.0, 5mM EDTA, 150mM NaCl, 1% (w/v) Triton-X-100,
1% (w/v) sodium deoxycholate, 0.5% (w/v) SDS; 3min) and a high-pressure water
wash (10 s). Protein complexes left bound to FN or Tf were washed ﬁve times using
PBS, recovered by scraping in 100 ml recovery solution (125mM Tris-HCl, pH 6.8,
1% (w/v) SDS, 15% (v/v) b-mercaptoethanol) and incubated at 70 C for 5–10min.
Where applicable, a proportion of each sample was precipitated from solution by
addition of four volumes  20 C acetone, incubated for 3.5–12 h on dry ice and
resuspended in reducing sample buffer for SDS-polyacrylamide gel electrophoresis
(SDS–PAGE) and immunoblot analyses.
To generate WCLs of cells spread on FN or Tf, the medium from each dish was
aspirated and centrifuged (300 g, 4min) to collect non-adherent cells. Lysates of
adherent cells were then collected by scraping in lysis buffer (150mM NaCl, 25mM
Tris, 2% (w/v) Triton-X-100, 0.5mM AEBSF, 10 mgml 1 leupeptin, 10mgml 1
aprotonin, 10mM NaF, 2mM Na3VO4, pH 7.4; 2min). To ensure equal numbers
of cells were used in all conditions, lysed cells were aspirated from each dish and
mixed with the cell pellet formed by centrifugation of non-adherent cells collected
from corresponding dishes. Finally, the non-solubilized material was removed by
centrifugation (22,000 g, 15min, 4 C).
Immunoblotting. Protein samples were separated by SDS–PAGE (4–12% Bis–Tris
gels; Invitrogen) and transferred to nitrocellulose membrane (Whatman, Maid-
stone, UK). Membranes were blocked for 60min at room temperature (RT) using
Odyssey blocking buffer (Sigma-Aldrich), and then probed overnight with primary
antibodies diluted in blocking buffer in Tris-buffered saline (TBS; 10mM Tris-HCl,
pH 7.4, 150mM NaCl) containing 0.05% Tween-20 (TBST) at 4 C. Membranes
were washed for 30min using PBS, and then incubated with the appropriate
ﬂuorophore-conjugated secondary antibody diluted in blocking buffer in TBST for
30min at RT in the dark. Membranes were washed for 30min in the dark using
PBS, and then scanned using the Odyssey infrared imaging system (LI-COR
Biosciences). Uncropped images of all membranes are displayed in Supplementary
Figs 5 and 6.
Proteolytic digestion and phosphopeptide enrichment. For proteomic analyses,
protein samples were separated by SDS–PAGE. Samples were allowed to migrate
approximately half way down a 4–12% Bis–Tris gel), stained for 60min with
Instant Blue (Expedeon, Cambridgeshire, UK), and washed in water overnight at
4 C. Gel lanes were excised and divided into 15 slices, and each gel slice was then
processed using an in-gel tryptic digestion procedure as described previously46 with
modiﬁcations8.
For phosphoproteomic analyses, protein samples were reduced using 10mM
dithiotheitol for 60min at 56 C and then alkylated using 15mM iodoacetamide
(IAM; 45min, RT). Proteins were precipitated from solution by addition of four
volumes  20 C acetone, incubated for 3.5–12 h on dry ice. Following
centrifugation (16,000 g, 15min, 4 C), the precipitated protein pellet was washed
twice with  20 C acetone, and then dried for 20–30min in a fume hood. Protein
pellets were resuspended in 50mM NH4HCO3 containing 0.2% (w/v) RapiGest
Surfactant (Waters, Manchester, UK) and digested with trypsin (Promega,
Madison, WI, USA) at an enzyme:substrate ratio of 1:50–1:100 (overnight, 37 C).
Digested samples were acidiﬁed to 0.5–1% (v/v) triﬂuoroacetic acid (TFA),
incubated at 37 C for 45min, and centrifuged at 22,000 g for 10min to remove
water-insoluble RapiGest by-products.
Peptides were desalted using Oasis HLB sample extraction columns (Waters),
and eluted in phosphopeptide enrichment binding solution (65% acetonitrile
(ACN), 2% TFA, saturated with glutamic acid, pH 2–3). Phosphopeptides were
enriched by incubation with titanium dioxide enrichment beads (Glygen,
Columbia, MD, USA) for 60min at RT. Beads were then washed three times, ﬁrstly
using binding solution, then wash solution 1 (0.5% (v/v) TFA, 65% (v/v) ACN) and
ﬁnally wash solution 2 (65% (v/v) ACN, 0.1% (v/v) TFA). Phosphopeptides were
acidiﬁed to pH 2–3 using TFA, and then eluted from beads by incubating with
elution solution (300mM ammonium hydroxide, 5% (v/v) ACN; 5min, RT).
Phosphopeptide-enriched samples were desalted twice on reverse-phase ZipTips
containing C18 media (Millipore). Peptides were eluted using 50% (v/v) ACN in
0.1% (v/v) formic acid (FA), dried to completion and resuspended in 5% ACN,
0.1% FA for tandem mass spectrometric (LC-MS/MS) analysis.
LC-MS/MS analyses and data analysis. Peptide analysis by LC-MS/MS was
performed using an UltiMate 3000 Rapid Separation LC (RSLC, Dionex Cor-
poration, Sunnyvale, CA, USA) coupled to an Orbitrap Elite mass spectrometer
(Thermo Fisher Scientiﬁc). Peptides were separated on a bridged ethyl hybrid C18
analytical column (250mm 75mm i.d., 1.7 mm particle size, Waters) over a 45-
min (proteomic analyses) or 165min (phosphoproteomic analyses) gradient from 8
to 33% (v/v) ACN in 0.1% (v/v) FA. LC-MS/MS analyses were operated in data-
dependent mode to automatically select peptides for fragmentation by collision-
induced dissociation. For phosphoproteomic analyses, multistage activation was
enabled to fragment product ions resulting from neutral loss of phosphoric acid, as
described previously47.
Tandem mass spectra were extracted using extract_msn (Thermo Fisher
Scientiﬁc) executed in Mascot Daemon (version 2.2.2; Matrix Science). Peak lists
were searched against a modiﬁed version of the IPI Human database (version 3.70),
modiﬁed to contain additional contaminant and reagent sequences of non-human
origin. Database searching was performed using an in-house Mascot server
(version 2.2.03; Matrix Science)48. Only tryptic peptides were considered. A
maximum of one missed cleavage was permitted, with a peptide mass tolerance of
5 p.p.m. and an MS/MS tolerance of 0.5Da. Monoisotopic precursor mass values
were used, and only doubly and triply charged precursor ions were considered.
Carbamidomethylated cysteine was set as a ﬁxed modiﬁcation, while serine,
threonine and tyrosine phosphorylation and methionine oxidation were set as
variable modiﬁcations. Data generated by Mascot were validated using Scaffold
(version 3.6.5, Proteome Software, Portland, OR, USA). Protein identiﬁcations
were accepted if they were assigned at least two unique peptides and could be
established with at least 90% probability at the peptide level and at least 99%
probability at the protein level. Individual phosphopeptide identiﬁcations (based
on one unique peptide) were accepted if they could be established with at least 95%
probability at the peptide level and at least 80% probability at the protein level. All
detected proteins and phosphopeptides are displayed in Supplementary Data 1 and
3, respectively.
To identify adhesion complex-speciﬁc proteins and phosphopeptides, adhesion
complexes and controls were compared by spectral counting. For protein
identiﬁcation, all proteins exhibiting at least a twofold enrichment to adhesion
complexes compared with control identiﬁcations were deemed adhesion complex-
speciﬁc (based on mean normalized spectral counts across three biological
replicates; minimum of six spectral counts per protein; Supplementary Data 2). For
phosphopeptide identiﬁcation, all phosphopeptides exhibiting at least a ninefold
enrichment to adhesion complexes compared with control identiﬁcations (42 s.d.
above mean fold change) were deemed adhesion complex-speciﬁc (based on mean
spectral counts across three adhesion complex isolations (ﬁve LC-MS/MS
analyses); minimum of 2 spectral counts per peptide; Supplementary Data 4).
Phosphorylation site localization scores were assigned according to the Mascot
Delta score49 using an in-house set-up.
GO enrichment analyses. GO enrichment analyses were performed using the
online bioinformatic tools available via the Database for Annotation, Visualization
and Integrated Discovery (DAVID; version 6.7; http://david.abcc.ncifcrf.gov/
home.jsp)50,51, utilizing two of the available GO categories: molecular function and
BP. Protein lists were searched using the IPI IDs, as assigned by Scaffold or as
supplied for published data sets23,24. The background data set used for analyses was
the Homo sapiens genome. GO terms with Bonferroni-corrected P value o0.05,
and at least two proteins per term were considered signiﬁcantly enriched.
PPI network analyses. PPI network analyses were performed using Cytoscape
(version 2.8.1)52. Proteins were mapped onto a merged human interactome
comprising PPIs listed in the Protein Interaction Network Analysis (release date
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10th December 2012)53 and a literature-curated database of integrin-associated
adhesion complex proteins7.
Kinase prediction analysis. Adhesion complex-speciﬁc phosphorylation sites
were analysed using the Group-based Prediction System (GPS; version 2.1.2)31. To
minimize false positives, the high threshold false positive rate was applied (2% for
serine/threonine kinases; 4% for tyrosine kinases). Of the 31 phosphorylation sites
in the data set that have previously been identiﬁed as a substrate for a particular
kinase, 22 (70%) were matched to the correct kinase by the kinase prediction tool
(Supplementary Data 10). These included sites such as pY576 and pY577 on FAK
that are well-deﬁned substrates for the tyrosine kinase Src, as well as the
autophosphorylation site on FAK pY397. Of the remaining nine phosphorylation
sites that were not matched to the correct kinase, two were identiﬁed as substrates
for kinases that are not components of the kinase prediction tool, four were
predicted to be phosphorylated by a different isoform or family member of the
reported upstream kinase, and four were not assigned a predicted upstream kinase.
Immunoﬂuorescence microscopy. A375-SM cells or HFFs were spread for
120min at 37 C, 5% (v/v) CO2 on glass-bottomed dishes (10mm glass diameter,
35mm plate diameter; MatTek Co., Ashland, MA, USA) coated with 10 mgml 1
FN. Where applicable, spread cells were incubated with the CDK1-speciﬁc inhi-
bitor RO-3306 (10 mM; Millipore), CGP74514A (5mM, Millipore), Roscovitone
(20 mM, Cell Signaling) or DMSO for 60min at 37 C, 8% (v/v) CO2. Cells were
ﬁxed in 4% (w/v) paraformaldehyde for 10min, washed twice with PBS and per-
meabilized using 0.5% (w/v) Triton-X-100 in PBS for 5min. Cells were then
washed twice with PBS and glass-bottomed dishes were blocked using 0.1M glycine
in PBS (60min, RT). Cells were incubated with primary antibodies (30min, RT),
and then washed with PBS and incubated for 30min with the appropriate sec-
ondary antibodies and, where applicable, Alexa 594-conjugated Phalloidin (Invi-
trogen). Finally, glass-bottomed dishes were washed with PBS a further three times
before imaging.
Images were acquired on an inverted confocal microscope (TCS SP5 Acousto-
Optical Beam Splitter; Leica, Wetzlar, Germany) using a  63 objective (HCX Plan
Apochromat, NA 1.25) and LCS software (Leica). Alternatively, images were
acquired on a spinning-disk confocal inverted microscope (Marianas; 3i, Denver,
CO, USA) using a  63 objective (Plan Apochromat, NA 1.4) and SlideBook 5.0
software (3i).
References
1. Legate, K. R., Wickstro¨m, S. A. & Fa¨ssler, R. Genetic and cell biological analysis
of integrin outside-in signaling. Genes Dev. 23, 397–418 (2009).
2. Schwartz, M. A. Integrin signaling revisited. Trends Cell Biol. 11, 466–470
(2001).
3. Wolfenson, H., Lavelin, I. & Geiger, B. Dynamic regulation of the structure and
functions of integrin adhesions. Dev. Cell 24, 447–458 (2013).
4. Wehrle-Haller, B. & Imhof, B. A. Integrin-dependent pathologies. J. Pathol.
200, 481–487 (2003).
5. Winograd-Katz, S. E., Fa¨ssler, R., Geiger, B. & Legate, K. R. The integrin
adhesome: from genes and proteins to human disease. Nat. Rev. Mol. Cell Biol.
15, 273–288 (2014).
6. Zaidel-Bar, R. & Geiger, B. The switchable integrin adhesome. J. Cell Sci. 123,
1385–1388 (2010).
7. Zaidel-Bar, R., Itzkovitz, S., Ma’ayan, A., Iyengar, R. & Geiger, B. Functional
atlas of the integrin adhesome. Nat. Cell Biol. 9, 858–867 (2007).
8. Humphries, J. D. et al. Proteomic analysis of integrin-associated complexes
identiﬁes RCC2 as a dual regulator of Rac1 and Arf6. Sci. Signal. 2, ra51
(2009).
9. Kuo, J.-C., Han, X., Hsiao, C.-T., Yates Iii, J. R. & Waterman, C. M. Analysis of
the myosin-II-responsive focal adhesion proteome reveals a role for b-Pix in
negative regulation of focal adhesion maturation. Nat. Cell Biol. 13, 383–393
(2011).
10. Schiller, H. B., Friedel, C. C., Boulegue, C. & Fassler, R. Quantitative proteomics
of the integrin adhesome show a myosin II-dependent recruitment of LIM
domain proteins. EMBO Rep. 12, 259–266 (2011).
11. Schiller, H. B. et al. b1- and av-class integrins cooperate to regulate myosin II
during rigidity sensing of ﬁbronectin-based microenvironments. Nat. Cell Biol.
15, 625–636 (2013).
12. Byron, A., Humphries, J. D., Craig, S. E., Knight, D. & Humphries, M. J.
Proteomic analysis of a4b1 integrin adhesion complexes reveals a-subunit-
dependent protein recruitment. Proteomics 12, 2107–2114 (2012).
13. Geiger, T. & Zaidel-Bar, R. Opening the ﬂoodgates: proteomics and the integrin
adhesome. Curr. Opin. Cell Biol. 24, 562–568 (2012).
14. Hunter, T. Why nature chose phosphate to modify proteins. Philos. Trans. R.
Soc. B Biol. Sci. 367, 2513–2516 (2012).
15. Mitra, S. K. & Schlaepfer, D. D. Integrin-regulated FAK–Src signaling in
normal and cancer cells. Curr. Opin. Cell Biol. 18, 516–523 (2006).
16. Deﬁlippi, P., Di Stefano, P. & Cabodi, S. p130Cas: a versatile scaffold in
signaling networks. Trends Cell Biol. 16, 257–263 (2006).
17. Deakin, N. O. & Turner, C. E. Paxillin comes of age. J. Cell Sci. 121, 2435–2444
(2008).
18. Panetti, T. S. Tyrosine phosphorylation of paxillin, FAK, and p130CAS: effects
on cell spreading and migration. Front. Biosci. 7, d143–d150 (2002).
19. Kirchner, J., Kam, Z., Tzur, G., Bershadsky, A. D. & Geiger, B. Live-cell
monitoring of tyrosine phosphorylation in focal adhesions following
microtubule disruption. J. Cell Sci. 116, 975–986 (2003).
20. Iyer, V. V., Ballestrem, C., Kirchner, J., Geiger, B. & Schaller, M. D.
Measurement of protein tyrosine phosphorylation in cell adhesion. Methods
Mol. Biol. 294, 289–302 (2005).
21. Zaidel-Bar, R., Ballestrem, C., Kam, Z. & Geiger, B. Early molecular events in
the assembly of matrix adhesions at the leading edge of migrating cells.
J. Cell Sci. 116, 4605–4613 (2003).
22. Chen, Y. et al. Combined integrin phosphoproteomic analyses and siRNA-
based functional screening identiﬁed key regulators for cancer cell adhesion and
migration. Cancer Res. 69, 3713–3720 (2009).
23. Olsen, J. V. et al. Quantitative phosphoproteomics reveals widespread full
phosphorylation site occupancy during mitosis. Sci. Signal. 3, ra3–ra3 (2010).
24. Rigbolt, K. T. G. et al. System-wide temporal characterization of the proteome
and phosphoproteome of human embryonic stem cell differentiation. Sci.
Signal. 4, rs3 (2011).
25. Schaller, M. D. et al. Autophosphorylation of the focal adhesion kinase,
pp125FAK, directs SH2-dependent binding of pp60src. Mol. Cell. Biol. 14,
1680–1688 (1994).
26. Nojima, Y. et al. Integrin-mediated cell adhesion promotes tyrosine
phosphorylation of p130Cas, a Src homology 3-containing molecule having
multiple Src homology 2-binding motifs. J. Biol. Chem. 270, 15398–15402
(1995).
27. Schaller, M. D. & Parsons, J. T. pp125FAK-dependent tyrosine phosphorylation
of paxillin creates a high-afﬁnity binding site for Crk. Mol. Cell. Biol. 15,
2635–2645 (1995).
28. Kanshin, E., Michnick, S. & Thibault, P. Sample preparation and analytical
strategies for large-scale phosphoproteomics experiments. Semin. Cell Dev. Biol.
23, 843–853 (2012).
29. Olsen, J. V. et al. Global, in vivo, and site-speciﬁc phosphorylation dynamics in
signaling networks. Cell 127, 635–648 (2006).
30. Rosales, J. L. & Isseroff, R. R. Increased expression of a high molecular weight
(130 KD) protein kinase C isoform in a differentiation-defective ras-transfected
keratinocyte line. J. Cell Physiol. 164, 509–521 (1995).
31. Xue, Y. et al. GPS 2.0, a tool to predict kinase-speciﬁc phosphorylation sites in
hierarchy. Mol. Cell Proteomics 7, 1598–1608 (2008).
32. Malumbres, M. & Barbacid, M. Mammalian cyclin-dependent kinases. Trends
Biochem. Sci. 30, 630–641 (2005).
33. Vassilev, L. T. et al. Selective small-molecule inhibitor reveals critical mitotic
functions of human CDK1. Proc. Natl Acad. Sci. USA 103, 10660–10665 (2006).
34. Vassilev, L. T. Cell cycle synchronization at the G2/M phase border by
reversible inhibition of CDK1. Cell Cycle 5, 2555–2556 (2006).
35. Trost, M., Bridon, G., Desjardins, M. & Thibault, P. Subcellular
phosphoproteomics. Mass Spectrom. Rev. 29, 962–990 (2010).
36. Zaidel-Bar, R. Evolution of complexity in the integrin adhesome. J. Cell Biol.
186, 317–321 (2009).
37. Lim, W. A. & Pawson, T. Phosphotyrosine signaling: evolving a new cellular
communication system. Cell 142, 661–667 (2010).
38. Hoffmann, J.-E., Fermin, Y., Stricker, R. L., Ickstadt, K. & Zamir, E. Symmetric
exchange of multi-protein building blocks between stationary focal adhesions
and the cytosol. eLife 3 (2014).
39. Jin, J.-K. et al. Talin1 phosphorylation activates b1 integrins: a novel
mechanism to promote prostate cancer bone metastasis. Oncogene (2014).
40. Huang, C. et al. Talin phosphorylation by Cdk5 regulates Smurf1-mediated
talin head ubiquitylation and cell migration. Nat. Cell Biol. 11, 624–630 (2009).
41. Miyamoto, Y. et al. Cdk5 regulates differentiation of oligodendrocyte precursor
cells through the direct phosphorylation of paxillin. J. Cell Sci. 120, 4355–4366
(2007).
42. Curtis, M., Nikolopoulos, S. N. & Turner, C. E. Actopaxin is phosphorylated
during mitosis and is a substrate for cyclin B1/cdc2 kinase. Biochem. J. 363,
233–242 (2002).
43. Zhong, Z. et al. Cyclin D1/cyclin-dependent kinase 4 interacts with ﬁlamin A
and affects the migration and invasion potential of breast cancer cells. Cancer
Res. 70, 2105–2114 (2010).
44. Manes, T. et al. Alpha(v)beta3 integrin expression up-regulates cdc2, which
modulates cell migration. J. Cell Biol. 161, 817–826 (2003).
45. Liu, L. et al. Cyclin-dependent kinase inhibitors block leukocyte adhesion and
migration. J. Immunol. 180, 1808–1817 (2008).
46. Shevchenko, A. et al. A strategy for identifying gel-separated proteins in
sequence databases by MS alone. Biochem. Soc. Trans. 24, 893–896 (1996).
47. Schroeder, M. J., Shabanowitz, J., Schwartz, J. C., Hunt, D. F. & Coon, J. J. A
neutral loss activation method for improved phosphopeptide sequence analysis
by quadrupole ion trap mass spectrometry. Anal. Chem. 76, 3590–3598 (2004).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7265
12 NATURE COMMUNICATIONS | 6:6265 | DOI: 10.1038/ncomms7265 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
48. Perkins, D. N., Pappin, D. J., Creasy, D. M. & Cottrell, J. S. Probability-based
protein identiﬁcation by searching sequence databases using mass spectrometry
data. Electrophoresis 20, 3551–3567 (1999).
49. Savitski, M. M. et al. Conﬁdent phosphorylation site localization using the
Mascot delta score. Mol. Cell Proteomics 10 (2011).
50. Dennis, Jr G. et al. DAVID: Database for Annotation, Visualization, and
Integrated Discovery. Genome Biol. 4, P3 (2003).
51. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative
analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc.
4, 44–57 (2009).
52. Smoot, M. E., Ono, K., Ruscheinski, J., Wang, P.-L. & Ideker, T. Cytoscape 2.8:
new features for data integration and network visualization. Bioinformatics 27,
431–432 (2011).
53. Wu, J. et al. Integrated network analysis platform for protein-protein
interactions. Nat. Methods 6, 75–77 (2009).
54. Vizcaı´no, J. A. et al. ProteomeXchange provides globally coordinated
proteomics data submission and dissemination. Nat. Biotechnol. 32, 223–226
(2014).
Acknowledgements
We thank A. Million-Fre´million and N.R. Paul for assistance with adhesion complex
isolations, and C. Ballestrem and T.S. Nu¨hse for discussions. We are grateful to I.J. Fidler
and J.A. Wilkins for reagents and to the PRIDE team for assistance with data deposition to
the ProteomeXchange consortium. This work was supported by the Wellcome Trust (grant
092015 to M.J.H.), a Wellcome Trust Institutional Strategic Support Fund award (grant
097820 to the University of Manchester) and a Biotechnology and Biological Sciences
Research Council studentship (to J.R.). The mass spectrometers and microscopes used in
this study were purchased with grants from the Biotechnology and Biological Sciences
Research Council, Wellcome Trust and the University of Manchester Strategic Fund.
Author contributions
J.D.H., A.B. and M.J.H. conceived the project; J.R., A.B., J.D.H., S.W., M.C.J. and M.J.H.
designed the experiments; J.R., G.J. and M.C.J. performed the experiments; J.R., G.J., A.B.,
D.K., J.N.S. and J.D.H. analysed the data; J.R., G.J., A.B., M.C.J., J.D.H. and M.J.H.
interpreted the results; J.R. and M.J.H. wrote the paper; all authors read and approved the
manuscript.
Additional information
Accession codes: The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium54 via the PRIDE partner repository with the data set
identiﬁer PXD001578 and DOI 10.6019/PXD001578.
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests..
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Robertson, J. et al. Deﬁning the phospho-adhesome through the
phosphoproteomic analysis of integrin signalling. Nat. Commun. 6:6265
doi: 10.1038/ncomms7265 (2015).
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7265 ARTICLE
NATURE COMMUNICATIONS | 6:6265 | DOI: 10.1038/ncomms7265 | www.nature.com/naturecommunications 13
& 2015 Macmillan Publishers Limited. All rights reserved.
